Oral ganciclovir and valganciclovir prophylaxis may prevent reactivation of non-β herpesviruses in cytomegalovirus (CMV) D+/R- solid organ transplant (SOT) patients

被引：0
|
作者：
Razonable, RR
Brown, RA
Humar, A
Covington, E
Alecock, E
Paya, CV
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Roche Prod Ltd, Med Sci, Welwyn Garden City AL7 3AY, Herts, England
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2004年 / 4卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
658
引用
收藏
页码：337 / 337
页数：1
相关论文
共 35 条
  • [31] Tolerance of Anti-CMV Prophylaxis with Valganciclovir One-Year Treatment in D plus /R- Lung Transplant Patients. A Single-Center Retrospective Study
    Roy, C.
    de Verdiere, S. Colin
    Beaumont, L.
    Picard, C.
    de Miranda, S.
    Hamid, A.
    Brugiere, O.
    Parquin, F.
    Farfour, E.
    Roux, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S340 - S340
  • [32] Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D plus /R- solid organ transplant recipients
    San-Juan, R.
    Navarro, D.
    Garcia-Reyne, A.
    Montejo, M.
    Munoz, P.
    Carratala, J.
    Len, O.
    Fortun, J.
    Munoz-Cobo, B.
    Gimenez, E.
    Eworo, A.
    Sabe, N.
    Meije, Y.
    Martin-Davila, P.
    Andres, A.
    Delgado, J.
    Jimenez, C.
    Amat, P.
    Fernandez-Ruiz, M.
    Lopez-Medrano, F.
    Lumbreras, C.
    Aguado, J. M.
    TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (05) : 637 - 646
  • [33] COST-EFFECTIVENESS MODEL TO EVALUATE 200-DAY VS 100-DAY TREATMENT WITH VALGANCICLOVIR PROPHYLAXIS TO REDUCE CYTOMEGALOVIRUS DISEASE IN HIGH-RISK (D+/R-) KIDNEY TRANSPLANT RECIPIENT IN SPAIN
    Fernandez-Rivera, C.
    Torre-Cisneros, J.
    Guirado-Perich, L.
    Oyagueez, I
    Ruiz-beato, E.
    VALUE IN HEALTH, 2011, 14 (07) : A275 - A275
  • [34] COST-EFFECTIVENESS MODEL TO EVALUATE 200-DAYS VS 100-DAYS TREATMENT WITH VALGANCICLOVIR PROPHYLAXIS TO REDUCE CYTOMEGALOVIRUS DISEASE IN HIGH-RISK (D+/R-) KIDNEY TRANSPLANT RECIPIENT IN SPAIN
    Guirado-Perich, Luis
    Torre-Cisneros, Julian
    Fernandez-Rivera, Constantino
    Oyagueez, Itziar
    Varela, Cristina
    TRANSPLANT INTERNATIONAL, 2011, 24 : 62 - 62
  • [35] Epstein-Barr Virus Viral Load Monitoring in High Risk, EBV Donor Seropositive (D plus ), Recipient Seronegative (R-), Adult and Pediatric Solid Organ Transplant (SOT) Patients Decreases Early Posttransplant Lymphoroloferative Disorder (PTLD)
    Doucette, Karen
    Dicken, Bryan
    Bigam, David
    Preiksaitis, Jutta
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 472 - 472
1234